| CB |
Report |
Core operating EPS |
BEAT |
pred ~$6.85 vs. cons $6.67 (Q2 2026) |
MEDIUM |
| CB |
Report |
Underlying (ex-cat) combined ratio |
BEAT |
pred ~82.4% vs. cons 82.6% (Q2 2026) |
MEDIUM |
| CB |
Report |
P&C headline combined ratio |
BEAT |
pred ~84.8% vs. cons 85.7% (Q2 2026) |
MEDIUM |
| CB |
Guide |
Adjusted net investment income guide |
BETTER |
guide ~$1.86B vs. cons $1.83B (Q3 2026) |
MEDIUM |
| CB |
Guide |
Consolidated NPW growth outlook |
LOWER |
guide ~+4.0% vs. cons +5.5% (H2 2026) |
MEDIUM |
| CB |
Guide |
FY2026 EPS / tangible book value growth commentary |
BETTER |
guide ~+10% vs. cons +9% (FY2026) |
LOW |
| CB |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.2% |
— |
LOW |
| CB |
Return |
5-day cumulative residual |
-2.3% (FADE) |
Stock already up ~13% since June 22 into the print, so even a Q2 beat on core EPS/underlying ratio is likely 'priced in'; management's blunt Q1 commentary on accelerating large-account property price declines (25%→30%+) implies further deliberate NPW/premium shrinkage in H2, which should pull consensus H2 2026/FY2026 NPW and EPS estimates down over the following days, echoing the Q1 2026 pattern where headline metrics disappointed despite solid underlying trends—driving a fade rather than follow-through. |
LOW |